Table 2.
Clinical trials for the discussed neurological conditions that are registered with ClinicalTrials.gov and signified as “recruiting”, “enrolling by invitation”, “active not recruiting”, or “not yet recruiting” (as of October 2018).
| Conditions | ClinicalTrials.gov# | Phase | Allo/Auto | MSC source | Site of Injection | Locations |
|---|---|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | 1 | Autologous | Bone Marrow | Intrathecal | Poland | |
| 1 | Allogeneic | Wharton’s Jelly | Intrathecal | Poland | ||
| 1 | Autologous | Adipose | Intraspinal & Intrathecal | Poland | ||
| 1/2 | Autologous | Bone Marrow | Intrathecal | Brazil | ||
| 1/2 | Autologous | Adipose | Intravenous | Spain | ||
| 2 | Autologous | Adipose | Intrathecal | USA | ||
| 3 | Autologous | Bone Marrow | Intrathecal | USA | ||
| Alzheimer’s Disease | 1 | Allogeneic | Bone Marrow | Intravenous | USA | |
| 1/2 | Allogeneic | Umbilical Cord | Intracerebroventricular | South Korea | ||
| 1/2 | Allogeneic | Umbilical Cord | Intravenous | China | ||
| 1/2 | Autologous | Adipose | Intravenous | USA | ||
| 2 | Allogeneic | Bone Marrow | Intravenous | USA | ||
| Multiple System Atrophy | 1 | Autologous | Adipose | Intrathecal | USA | |
| 1 | Autologous | Bone Marrow | Intracarotid | South Korea | ||
| Parkinson’s Disease | 1 | Allogeneic | Umbilical Cord | Intravenous | China | |
| 1/2 | Allogeneic | Bone Marrow | Intravenous | USA | ||
| 1/2 | Allogeneic | Umbilical Cord | Intrathecal & Intravenous | Jordan |